Related Experiment Video
Updated: Dec 16, 2025

10:23
Evaluation of Caspase Activation to Assess Innate Immune Cell Death
Published on: January 20, 2023
3.7K
Engineering caspase 7 as an affinity reagent to capture proteolytic products
Amir S Razai1, Scott J Snipas2, Marcin Poreba2,3
1Graduate School of Biomedical Sciences, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA.
The FEBS Journal
|July 4, 2020
Summary
Researchers engineered a protease scaffold to create a product-only trap. This novel affinity reagent specifically recognizes apoptotic cells, demonstrating versatility for protease-based imaging agents.
Area of Science:
- Biochemistry
- Molecular Biology
- Protease Engineering
Background:
- Proteases exhibit high substrate specificity, suggesting their binding sites can be engineered into affinity reagents.
- Differentiating between protease substrates and products is crucial for understanding enzymatic activity and developing targeted therapies.
Purpose of the Study:
- To engineer a caspase 7-based scaffold capable of specifically trapping protease products.
- To develop a versatile affinity reagent for recognizing apoptotic cells and other targets.
Main Methods:
- Engineered a catalytically inactive caspase 7 mutant that adopts a substrate-binding conformation.
- Introduced three specific mutations to create a 'product-only trap' by compensating for charge changes upon product formation.
- Fused the engineered product trap with a fluorescent protein to create a cellular imaging agent.
Main Results:
- Successfully generated a caspase 7 variant that binds peptides with affinity comparable to the wild-type enzyme.
- Developed a 'product-only trap' that specifically recognizes protease cleavage products.
- Demonstrated that the hybrid fluorescent protein reagent specifically identifies apoptotic cells.
Conclusions:
- Protease scaffolds can be engineered into highly specific affinity reagents for trapping reaction products.
- This approach offers a versatile platform for developing novel affinity and imaging agents for various proteases.
- The developed reagent shows promise for specific detection of apoptotic cells and potentially other biological targets.

